QIAGEN N.V. Restructuring and Related Cost, Incurred Cost
QIAGEN N.V. (QGEN) reported Restructuring and Related Cost, Incurred Cost of $6.95 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2024-03-11
| Period end | Restructuring and Related Cost, Incurred Cost 12 month | Restructuring and Related Cost, Incurred Cost 24 month | Restructuring and Related Cost, Incurred Cost 36 month | Restructuring and Related Cost, Incurred Cost 36 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | $6.95M 20-F · filed 2024-03-11 | |||
| 2022-12-31 | $5.00M 20-F · filed 2024-03-11 | |||
| 2019-12-31 | $24.40M 20-F · filed 2021-03-05 | $24.00M 20-F · filed 2020-03-02 | ||
| 2018-12-31 | $25.00M 20-F · filed 2019-03-06 |